RecruitingNot ApplicableNCT03288948
Binocular Amblyopia Treatment
Sponsor
Retina Foundation of the Southwest
Enrollment
120 participants
Start Date
Aug 31, 2017
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.
Eligibility
Min Age: 4 YearsMax Age: 10 Years
Inclusion Criteria11
- age 4-10 y
- male and female
- strabismic, anisometropic, or combined mechanism amblyopia
- amblyopic eye best-corrected visual acuity 0.3-0.8 logMAR
- fellow eye best-corrected visual acuity ≤0.1 logMAR
- interocular visual acuity difference ≥0.3 logMAR
- wearing glasses (if needed) for 8 weeks or no change visual acuity with glasses at 2 visits
- weeks apart.
- child's ophthalmologist and family must be willing to forgo patching treatment during the 12-week study period
- parent's informed consent
- child must demonstrate understanding and ability to play binocular games
Exclusion Criteria5
- prematurity ≥8 weeks
- coexisting ocular or systemic disease
- developmental delay
- strabismus \>5pd
- any binocular amblyopia treatment in the past 3 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBinocular games for treatment of amblyopia
playing binocular games on a tablet platform 1 hour per day 5 days per week with reduced contrast for the fellow eye and high contrast for the amblyopic eye
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03288948
Related Trials
Optical Correction and Visual Functions of Adults With Amblyopia
NCT053949872 locations
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
NCT043102411 location
Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP). The Aim Of The Study Is To Evaluate Possible Beneficial Effects For Different Age Groups.
NCT074170461 location
Ocular Characteristics in Patients With Craniosynostosis
NCT069287271 location
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
NCT0652488258 locations